Genome-wide association study of major depressive disorder: New results, meta-analysis, and lessons learned
Wray, N.R., Pergadia, M.L., Blackwood, D.H., Penninx, B.W., Gordon, S.D., Nyholt, D.R., Ripke, S., MacIntyre, D.J., McGhee, K.A., Maclean, A.W., Smit, J.H., Hottenga, J.J., Willemsen, G., Middeldorp, C.M., de Geus, E.J., Lewis, C.M., McGuffin, P., Hickie, I.B., van den Oord, E.J., Liu, J.Z., Macgregor, S., McEvoy, B.P., Byrne, E.M., Medland, S.E., Statham, D.J., Henders, A.K., Heath, A.C., Montgomery, G.W., Martin, N.G., Boomsma, D.I., Madden, P.A., & Sullivan, P.F. (2012) Genome-wide association study of major depressive disorder: New results, meta-analysis, and lessons learned. Molecular Psychiatry, 17(1), pp. 36-48.
Major depressive disorder (MDD) is a common complex disorder with a partly genetic etiology. We conducted a genome-wide association study of the MDD2000+ sample (2431 cases, 3673 screened controls and >1 M imputed single-nucleotide polymorphisms (SNPs)). No SNPs achieved genome-wide significance either in the MDD2000+ study, or in meta-analysis with two other studies totaling 5763 cases and 6901 controls. These results imply that common variants of intermediate or large effect do not have main effects in the genetic architecture of MDD. Suggestive but notable results were:
(a) gene-based tests suggesting roles for adenylate cyclase 3 (ADCY3, 2p23.3) and galanin (GAL, 11q13.3); published functional evidence relates both of these to MDD and serotonergic signaling;
(b) support for the bipolar disorder risk variant SNP rs1006737 in CACNA1C (P=0.020, odds ratio=1.10), and;
(c) lack of support for rs2251219, a SNP identified in a meta-analysis of affective disorder studies (P=0.51).
We estimate that sample sizes 1.8- to 2.4-fold greater are needed for association studies of MDD compared with those for schizophrenia to detect variants that explain the same proportion of total variance in liability. Larger study cohorts characterized for genetic and environmental risk factors accumulated prospectively are likely to be needed to dissect more fully the etiology of MDD.
Impact and interest:
Citation counts are sourced monthly from and citation databases.
These databases contain citations from different subsets of available publications and different time periods and thus the citation count from each is usually different. Some works are not in either database and no count is displayed. Scopus includes citations from articles published in 1996 onwards, and Web of Science® generally from 1980 onwards.
Citations counts from theindexing service can be viewed at the linked Google Scholar™ search.
Full-text downloads displays the total number of times this work’s files (e.g., a PDF) have been downloaded from QUT ePrints as well as the number of downloads in the previous 365 days. The count includes downloads for all files if a work has more than one.
|Item Type:||Journal Article|
|Keywords:||Adenylate Cyclase/*genetics, Adolescent, Adult, Calcium Channels, L-Type/*genetics, Depressive Disorder, Major/*genetics, Female, Galanin/*genetics, Genetic Predisposition to Disease/*genetics, Genome-Wide Association Study, Genotype, Humans, Male, Middle Aged, Odds Ratio, Polymorphism, Single Nucleotide/*genetics, Principal Component Analysis, Sex Factors, Young Adult|
|Divisions:||Current > QUT Faculties and Divisions > Faculty of Health
Current > Institutes > Institute of Health and Biomedical Innovation
|Deposited On:||14 Jan 2016 01:14|
|Last Modified:||11 Apr 2017 01:41|
Repository Staff Only: item control page